Halozyme Therapeutics, Inc(NASDAQ:HALO) 
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that ...
Website: http://www.halozyme.com
Founded: 1998
Full Time Employees: 132
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 60.72
H 60.98
L 59.11
C 59.77
V 2,292,512
10EMA 59.77
20EMA 59.77
60EMA 59.77
120EMA 59.77
250EMA 59.77